Editorial to “Carbon dioxide insufflation to facilitate epicardial access in extracorporeal membrane oxygenation-supported ventricular tachycardia ablation”: Blowing an exhaled gas for easy and safe pericardial puncture
{"title":"Editorial to “Carbon dioxide insufflation to facilitate epicardial access in extracorporeal membrane oxygenation-supported ventricular tachycardia ablation”: Blowing an exhaled gas for easy and safe pericardial puncture","authors":"Ugur Canpolat MD","doi":"10.1002/joa3.13216","DOIUrl":null,"url":null,"abstract":"<p>In the current issue of the <i>Journal of Arrhythmia</i>, Takase et al.<span><sup>1</sup></span> reported a challenging patient with scleroderma-related structural heart disease who was admitted with recurrent ventricular tachycardia (VT) episodes after a failed endocardial catheter ablation alone. The authors' first challenge during an index catheter ablation was the hemodynamic instability during VT for mapping. The author's second challenge during the planned second catheter ablation was the anatomical neighboring of the left hepatic lobe to the subxiphoid epicardial access route. The authors have overcome both challenges with the carbon dioxide (CO<sub>2</sub>) insufflation method for facilitating the visibility of intrapericardial space and the hemodynamic support of extracorporeal membrane oxygenation. The endocardial and epicardial catheter ablation was successfully performed by overcoming these technical obstacles.</p><p>Catheter ablation is advised to reduce recurrent VT and the need for implantable cardioverter defibrillator shocks in patients with non-ischemic cardiomyopathy (NICM) and recurrent sustained monomorphic VT when antiarrhythmic medications are ineffective, contraindicated, or poorly tolerated.<span><sup>2</sup></span> VT developed as a result of left or right ventricular myocardial involvement, and successful catheter ablation has been previously reported in patients with systemic scleroderma.<span><sup>3</sup></span> However, due to the underlying mechanism of myocardial disease and VT (primarily caused by scar-related reentry<span><sup>3</sup></span>), endocardial catheter ablation alone might be insufficient to eliminate the VT focus. Furthermore, the contribution of ventricular scar to the electrophysiological abnormalities targeted for endocardial ablation of unstable VT differs between ischemic and non-ischemic cardiomyopathies. Since the case of Takase et al. also involved VT due to non-ischemic etiology, endocardial substrate ablation alone may have failed for hemodynamically unstable VT. Epicardial catheter ablation of VT can be useful after the failure of endocardial ablation because of the higher rate of the intramyocardial and epicardial substrate in patients with NICM.<span><sup>2</sup></span> Demonstrating a three-dimensional hyperboloid VT circuit structure is another reason that endocardial catheter ablation alone is ineffective in some patients.<span><sup>4</sup></span> Before epicardial catheter ablation, pre-procedural imaging techniques, such as cardiac computed tomography or magnetic resonance imaging, may play a critical role in procedural guidance and preventing complications by indicating neighboring structures.<span><sup>2</sup></span> Accessing the epicardium is typically achieved through a subxiphoid and trans pericardial puncture. However, epicardial access may be difficult due to anatomical obstacles and poor fluoroscopic visibility, which result in both acute and delayed complications. Carbon dioxide insufflation through the coronary sinus exit is a novel approach to address the technical challenges of epicardial access, especially in patients with minimal or no pericardial fluid (dry epicardium), and adhesions (previous history of cardiovascular surgery, epicardial catheter ablation, or pericarditis). The technique is safe and effective, minimizing the risks associated with conventional approaches.<span><sup>5</sup></span> It also delineates the localized pericardial adhesions in high-risk patients and guides for target epicardial access sites.<span><sup>6</sup></span> This technique may show that epicardial access is impossible in some patients with advanced pericardial adhesions.<span><sup>6</sup></span> Takase et al.<span><sup>1</sup></span> noted that an important step in the procedure is to avoid perforating the coronary veins that run toward the left ventricular muscle. Observing premature ventricular contractions after advancing the wire into those branches and staining of the myocardium following contrast injection are key findings indicating inappropriate coronary vein perforation. Chaumont et al.<span><sup>7</sup></span> reported similar success rates of epicardial access via conventional versus CO<sub>2</sub> insufflation method. However, the CO<sub>2</sub> insufflation method was significantly linked to lower rates of major complications and bleeding compared to conventional access. This multicenter study illustrates that the primary limitation of distal coronary venous exit for CO<sub>2</sub> insufflation is the lengthy nature of the technique, which involves several laborious steps. In addition to its well-known efficacy and safety profile, the technique can be performed easily and successfully in both low- and high-volume centers. Additionally, this technique displaces the diaphragm downward due to the carbon dioxide injected into the pericardial space, pushing the left lobe of the liver away from the epicardial access route.<span><sup>1</sup></span> In conclusion, although the CO<sub>2</sub> insufflation technique involves time-consuming steps, it is a safe and effective method for achieving epicardial access in patients undergoing VT catheter ablation. This technique, which demonstrates pericardial adhesions before puncture, should be considered, especially in high-risk patients requiring epicardial access.</p><p>Authors declare no conflict of interests for this article.</p>","PeriodicalId":15174,"journal":{"name":"Journal of Arrhythmia","volume":"41 1","pages":""},"PeriodicalIF":1.7000,"publicationDate":"2025-01-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11730733/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Arrhythmia","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/joa3.13216","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0
Abstract
In the current issue of the Journal of Arrhythmia, Takase et al.1 reported a challenging patient with scleroderma-related structural heart disease who was admitted with recurrent ventricular tachycardia (VT) episodes after a failed endocardial catheter ablation alone. The authors' first challenge during an index catheter ablation was the hemodynamic instability during VT for mapping. The author's second challenge during the planned second catheter ablation was the anatomical neighboring of the left hepatic lobe to the subxiphoid epicardial access route. The authors have overcome both challenges with the carbon dioxide (CO2) insufflation method for facilitating the visibility of intrapericardial space and the hemodynamic support of extracorporeal membrane oxygenation. The endocardial and epicardial catheter ablation was successfully performed by overcoming these technical obstacles.
Catheter ablation is advised to reduce recurrent VT and the need for implantable cardioverter defibrillator shocks in patients with non-ischemic cardiomyopathy (NICM) and recurrent sustained monomorphic VT when antiarrhythmic medications are ineffective, contraindicated, or poorly tolerated.2 VT developed as a result of left or right ventricular myocardial involvement, and successful catheter ablation has been previously reported in patients with systemic scleroderma.3 However, due to the underlying mechanism of myocardial disease and VT (primarily caused by scar-related reentry3), endocardial catheter ablation alone might be insufficient to eliminate the VT focus. Furthermore, the contribution of ventricular scar to the electrophysiological abnormalities targeted for endocardial ablation of unstable VT differs between ischemic and non-ischemic cardiomyopathies. Since the case of Takase et al. also involved VT due to non-ischemic etiology, endocardial substrate ablation alone may have failed for hemodynamically unstable VT. Epicardial catheter ablation of VT can be useful after the failure of endocardial ablation because of the higher rate of the intramyocardial and epicardial substrate in patients with NICM.2 Demonstrating a three-dimensional hyperboloid VT circuit structure is another reason that endocardial catheter ablation alone is ineffective in some patients.4 Before epicardial catheter ablation, pre-procedural imaging techniques, such as cardiac computed tomography or magnetic resonance imaging, may play a critical role in procedural guidance and preventing complications by indicating neighboring structures.2 Accessing the epicardium is typically achieved through a subxiphoid and trans pericardial puncture. However, epicardial access may be difficult due to anatomical obstacles and poor fluoroscopic visibility, which result in both acute and delayed complications. Carbon dioxide insufflation through the coronary sinus exit is a novel approach to address the technical challenges of epicardial access, especially in patients with minimal or no pericardial fluid (dry epicardium), and adhesions (previous history of cardiovascular surgery, epicardial catheter ablation, or pericarditis). The technique is safe and effective, minimizing the risks associated with conventional approaches.5 It also delineates the localized pericardial adhesions in high-risk patients and guides for target epicardial access sites.6 This technique may show that epicardial access is impossible in some patients with advanced pericardial adhesions.6 Takase et al.1 noted that an important step in the procedure is to avoid perforating the coronary veins that run toward the left ventricular muscle. Observing premature ventricular contractions after advancing the wire into those branches and staining of the myocardium following contrast injection are key findings indicating inappropriate coronary vein perforation. Chaumont et al.7 reported similar success rates of epicardial access via conventional versus CO2 insufflation method. However, the CO2 insufflation method was significantly linked to lower rates of major complications and bleeding compared to conventional access. This multicenter study illustrates that the primary limitation of distal coronary venous exit for CO2 insufflation is the lengthy nature of the technique, which involves several laborious steps. In addition to its well-known efficacy and safety profile, the technique can be performed easily and successfully in both low- and high-volume centers. Additionally, this technique displaces the diaphragm downward due to the carbon dioxide injected into the pericardial space, pushing the left lobe of the liver away from the epicardial access route.1 In conclusion, although the CO2 insufflation technique involves time-consuming steps, it is a safe and effective method for achieving epicardial access in patients undergoing VT catheter ablation. This technique, which demonstrates pericardial adhesions before puncture, should be considered, especially in high-risk patients requiring epicardial access.
Authors declare no conflict of interests for this article.
在最新一期的《心律失常杂志》上,Takase等报道了一例硬皮病相关结构性心脏病患者,在单独心内膜导管消融失败后复发性室性心动过速(VT)发作。作者在索引导管消融期间的第一个挑战是在VT测图期间的血流动力学不稳定。作者在计划的第二次导管消融过程中的第二个挑战是左肝叶与剑突下心外膜通路的解剖邻近。作者已经克服了这两个挑战,二氧化碳(CO2)注入方法,以促进心包内空间的可见性和体外膜氧合的血流动力学支持。通过克服这些技术障碍,心内膜和心外膜导管消融得以成功实施。对于非缺血性心肌病(NICM)患者,当抗心律失常药物无效、禁忌症或耐受性差时,建议导管消融以减少复发性室性心动过速和植入式心律转复除颤器电击的需要室性心动过速是左室或右室心肌受累的结果,在系统性硬皮病患者中,既往有导管消融成功的报道然而,由于心肌疾病和室速的潜在机制(主要由疤痕相关性再入引起3),单心内膜导管消融可能不足以消除室速病灶。此外,在缺血性和非缺血性心肌病中,心室疤痕对心内膜消融不稳定室速的电生理异常的贡献不同。由于Takase等人的病例也因非缺血性病因而涉及室性心动过速,单独心内膜底物消融可能对血流动力学不稳定的室性心动过速无效。心内膜消融失败后,心外膜导管消融室性心动过速是有用的,因为nicm患者的心内膜内底物和心外膜底物的发生率较高在心外膜导管消融前,术前成像技术,如心脏计算机断层扫描或磁共振成像,可以通过指示邻近结构在手术指导和预防并发症方面发挥关键作用通常通过剑突下和经心包穿刺进入心外膜。然而,由于解剖障碍和较差的透视能见度,心外膜进入可能很困难,这导致急性和延迟并发症。通过冠状动脉窦出口二氧化碳注入是解决心外膜通道技术挑战的一种新方法,特别是对于心包积液很少或没有(心外膜干燥)和粘连(既往心血管手术史、心外膜导管消融或心包炎)的患者。该技术安全有效,将传统方法的风险降至最低它还描述了高危患者的局部心包粘连,并指导了目标心外膜通路的位置这项技术可能表明,在一些有严重心包粘连的患者中,无法进入心外膜Takase等人指出,手术的一个重要步骤是避免刺穿通向左心室肌的冠状静脉。观察导线进入这些分支后室性早搏和注射造影剂后心肌染色是提示不适当冠状静脉穿孔的关键发现。Chaumont et al.7报道了通过常规方法与CO2充气法进行心外膜插管的成功率相似。然而,与传统途径相比,CO2充气方法与较低的主要并发症和出血率显着相关。这项多中心研究表明,冠状动脉远端静脉出口用于二氧化碳注入的主要限制是该技术的冗长性,涉及几个费力的步骤。除了其众所周知的有效性和安全性外,该技术可以在低容量和高容量中心轻松成功地进行。此外,由于注入心包间隙的二氧化碳,这种技术使横膈膜向下移位,将左肝叶推离心外膜通路1综上所述,尽管CO2灌注技术耗时,但对于接受VT导管消融的患者来说,它是一种安全有效的实现心外膜通路的方法。该技术在穿刺前可显示心包粘连,应予以考虑,特别是在需要进入心外膜的高危患者中。 作者声明本文无利益冲突。